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Abstract
Background: Understanding the characteristics of communication that foster patient-centered outcomes amid
serious illness are essential for the science of palliative care. However, epidemiological cohort studies that directly
observe clinical conversations can be challenging to conduct in the natural setting. We describe the successful
enrollment, observation and data collection methods of the ongoing Palliative Care Communication Research
Initiative (PCCRI).
Methods: The PCCRI is a multi-site cohort study of naturally occurring inpatient palliative care consultations. The
6-month cohort data includes directly observed and audio-recorded palliative care consultations (up to first 3 visits);
patient/proxy/clinician self-report questionnaires both before and the day after consultation; post-consultation in-depth
interviews; and medical/administrative records.
Results: One hundred fourteen patients or their proxies enrolled in PCCRI during Enrollment Year One (of Three).
Seventy percent of eligible patients/proxies were invited to hear about a communication research study (188/269);
60 % of them ultimately enrolled in the PCCRI (114/188), resulting in a 42 % sampling proportion (114/269 eligible).
All PC clinicians at study sites were invited to participate; all 45 participated.
Conclusions: Epidemiologic study of patient-family-clinician communication in palliative care settings is feasible and
acceptable to patients, proxies and clinicians. We detail the successful PCCRI methods for enrollment, direct
observation and data collection for this complex “field” environment.
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Background
Our findings suggest that the most fundamental
medical choice patients with [serious illness] face—the
decision between life-extending therapy and comfort
care—may be highly influenced by their understanding
of their prognoses [1]. –SUPPORT Study, 1996
Communicating about prognosis is important for
decision-making in serious illness [2–12]. However,
prognosis discussions can be daunting for physicians,
patients and families [13–16], resulting in patterns of
prognostic avoidance or obfuscation in the usual care of
seriously ill patients [14, 17–19]. Indeed, these endemic
norms makes studying prognosis communication in the
natural setting quite challenging—resulting in nearly no
empirical data about the characteristics of prognosis
conversations that promote high quality treatment deci-
sions and better quality of life for patients with advanced
cancer.
Palliative care is grounded in fostering high quality
communication amid serious illness. Prognosis conversa-
tions are a fundamental feature of palliative care consul-
tations [20–22] and emerging evidence suggests that
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these discussions are a key ingredient [21–24] in palliative
care’s benefit to persons with advanced cancer [25–27].
Little is known, however, about how patients, families and
palliative care clinicians actually talk about prognoses in
the natural decision-making setting. Understanding these
existing patterns of communication is essential to identify
the approaches that promote preference-concordant treat-
ment decisions and enhance quality of life. The purpose of
the PCCRI is to understand the context, content, process,
and outcomes of prognosis communication as occurs nat-
urally during palliative care consultations. Because exist-
ing models of prognosis communication are in early
evolution [15, 28], the PCCRI uses a mixed-methods ap-
proach that measures features of prognosis conversations
having a priori conceptual importance (quantitative
component) and examines interactions ethnographically
(qualitative component) to expand our existing communi-
cation frameworks. Here, we describe the study design;
observation and measurement methods; and recruitment
experience during the first year of PCCRI enrollment.
Methods
Design overview
The PCCRI is a multi-site observational cohort study of
inpatient palliative care consultations as they naturally
occur in the hospital setting. We restricted this study to
the hospital setting because palliative care consultation
in the outpatient context is comparatively newer, less
frequent and highly variable in terms of reasons for re-
ferral [29, 30]. All participating patients or their health-
care proxies complete a brief pre-consultation (18 items)
and post-consultation (2 items) interviewer-administered
questionnaire. The initial consult visit and up to two
additional subsequent visits are audio-recorded and dir-
ectly observed using field observation methods. Up to
60 patient/proxy participants will complete an optional
extended interview regarding their experience of illness
and with the palliative care consultation. All participat-
ing palliative care clinicians complete a 35-item ques-
tionnaire about themselves at the time of enrollment
and a 3-item questionnaire after each consultation that
is about the patient's prognosis, performance status and
goals of medical treatments. Patients’ medical and ad-
ministrative records are collected at baseline, 1-month
and 6-months.
Conceptual foundation
Promoting patient-centered care in serious illness is a
major goal for healthcare in the 21st century [31–33].
Patient-centered care considers the patient’s unique ex-
perience of illness on shared ground with the clinician’s
perspective. Patient-centered care directs clinicians to
see the world both through the patient’s eyes and through
a clinical lens, and promotes meaningful decisions that
reflect each patient’s unique clinical context, personal
values and preferences [34–36].
Our conceptual model of Patient-Centered Prognosis
Communication [15, 20] is based upon prior work by
Epstein and Street [37, 38] and identifies four specific
and observable domains: 1) participants ENGAGING in
discussion about prognosis, including inviting discussion
of prognosis, eliciting preferences for information and
respecting opinions; 2) RESPONDING to presence of
emotion; 3) patient/family/clinician mutually INFORM-
ING about prognosis opinions and perspectives, and 4)
FRAMING uncertainty. Each of these overlapping and
mutually influenced domains assumes greater or lesser
importance depending on the clinical context. We define
“prognosis communication” to include prediction or an-
ticipatory guidance about illness course, including how
treatment options might influence such prognoses.
Measuring patient-centered communication can focus
on process and outcomes [36, 39]. We do both. Wide
agreement exists that good communication should pro-
mote patients feeling heard and understood and, ultim-
ately, match medical care to the patient’s unique
context, preferences and personal values—we consider
these to be patient-centered outcomes [32, 36, 37, 39].
However, process measures are less developed, largely
because few clinical situations are understood empiric-
ally well enough to know a priori how theoretically-
driven behaviors are organized to promote desired
outcomes [36, 39]. This research considers conversations
as important processes of patient-centered care.
Clinical setting
The University of Rochester Medical Center (URMC)
Inpatient Palliative Care Services
URMC is comprised of a 750-bed academic medical cen-
ter and a 261-bed community hospital, both located in the
city of Rochester, NY. The URMC PC inpatient consult-
ation service cares for over 1,600 patients per year –about
half of whom have advanced cancer–and is staffed by 24
attending physicians (rotating on 2-week blocks), 3 fellows
(rotating on 4-week blocks) and 5 nurse practitioners
(continuous).
University of California at San Francisco (UCSF) Inpatient
Palliative Care Services
UCSF’s Moffitt-Long Hospital is a 600-bed academic
medical center located in the city of San Francisco, CA.
The UCSF PC inpatient consultation service cares for
over 800 patients per year –about half of whom have ad-
vanced cancer–and is staffed by 9 attending physicians
(rotating on 1-week blocks), 4 physician fellows (rotating
on 1-month blocks), as well as 2 social workers, 1 clin-
ical nurse specialist, and 2 chaplains (all continuous).
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Participants
Clinician participants
All palliative care team clinicians are eligible to partici-
pate, including attending and fellow physicians, nurse
practitioners, social workers, and spiritual care providers.
Trainees rotating briefly with the palliative care team and
clinicians working with other services in the hospital may
be present at the time of audio recording (eg. resident phy-
sicians, medical students, bedside nurses, unit social
workers, etc.), but their names are removed from the
audio recording.
Patient (and healthcare proxy) participants
All English-speaking adult patients who are referred to
palliative care and whose primary life-limiting illness is a
metastatic cancer are eligible for this study. We define
“solid cancers” to include all non-hematologic malignan-
cies and lymphomas. We define “metastatic” to include
Stage 3 or 4 cancers or, if staging is incomplete, the oncol-
ogist’s clinical judgment about the presence of distant me-
tastases from a known primary cancer. We exclude
patients who are receiving hospice care or have a “Com-
fort Measures Only” designation in their Medical Orders
for Life Sustaining Treatments (MOSLT) at the time of re-
ferral because this study is focused on consultations where
active decision-making about disease-oriented treatments
is relevant. If potentially eligible patients lack basic
decision-making capacity (per clinical team determin-
ation), then the surrogate decision-makers are eligible to
participate. Surrogates are eligible if they speak English
and have assumed official Health Care Proxy status, either
by state law or patient assignment. Therefore, we refer to
surrogates in this study as "healthcare proxies".
Recruitment and enrollment
The sustained success of this project rests on the ability to
identify, approach, inform, consent and enroll participants
amid the usual workflow of the inpatient palliative care
consultation service. During a two-year preliminary study
funded by the National Palliative Care Research Center
[20–22, 24] as well as the pilot phase of the PCCRI, we de-
veloped and refined the following protocol with close col-
laboration of the clinical palliative care team:
Preliminary identification
When a patient is referred for palliative care consultation,
the accepting clinical provider identifies potentially eligible
patients using a PCCRI pocket eligibility card as needed
for reference. PCCRI Study Staff assist clinicians in deter-
mining eligibility questions or clarifications.
Initial approach
After the patient or family has met a member of the
clinical palliative care team, eligible patients or family
members are asked by a member of the clinical team
(URMC), or the study coordinator (UCSF) whether they
would be willing to hear more about the study. The
PCCRI Study Brochure is used to provide information
about the study (see Fig. 1). Patient or proxies who agree
to hear more about the study are given detailed informa-
tion as consistent with informed consent procedures by
the PCCRI Study Staff in their hospital room. Patients/
proxies who agree to participate sign written informed
consent.
Remuneration
Participating patients/proxies receive a total of $20 for
participation ($10 after each pre-post consultation ques-
tionnaire). Participating palliative care clinicians receive
$100 at the time of baseline questionnaire.
The study research coordinator documents all recruit-
ment efforts regarding eligibility, participation, and the
reasons for ineligibility, opting out or non-participation
(if reasons are offered).
Sampling approach
At each study site, 0–2 consultations with potentially eli-
gible patients typically occur each day. However, there are
days when substantially more eligible consultations hap-
pen. We approach potentially eligible patients in the order
that referrals occurred during the day, with the expect-
ation of enrolling up to two on any given day (depending
on staffing). When potentially eligible consultations co-
occur, we prioritize approaching patients from racial or
ethnic backgrounds that are historically underrepresented
in healthcare research.
Data collection & measurement instruments
We designed the PCCRI to understand the relation be-
tween clinical communication and patient-centered out-
comes (see Conceptual Foundation). In order to validly
accomplish this aim, the PCCRI includes self-report (eg.
patient perceptions & preferences; clinician perceptions),
direct observation & audio recording of palliative care
consultations and medical record abstraction (eg. disease
status; treatment utilization). The PCCRI study data are
collected from eight sources as described below: (1) hos-
pital medical & administrative record; (2) patient/proxy
baseline questionnaire; (3) palliative care clinician base-
line questionnaire; (4) digital recordings of the palliative
care conversations; (5) direct observation checklist &
field notes of the palliative care conversations; (6) pa-
tient/proxy post-consultation questionnaire; (7) palliative
care clinician post-consultation questionnaire; and (8) an
in depth post-consultation interview among a sub-
sample of patient/proxy participants. “Post-consultation”
here refers to the next calendar day following the first
recorded conversation with the palliative care team,
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regardless of whether the palliative care team continues to
care for the patient during the remaining hospitalization.
Hospital medical & administrative record
The research assistant identifies healthcare utilization
and the site of death of each study participant via 1-
month and 6-month interval telephone contact with
health care provider or family member contact provided
by the participant at time of enrollment. For any hospi-
talizations or hospice enrollment, we extract pertinent
treatment data (see outcomes) via a standard health ser-
vices utilization form used in related palliative care
health services research [40, 41].
Patient/Proxy baseline questionnaire
Following consent procedures, each patient or proxy par-
ticipant completes an 18-item interviewer-administered
questionnaire. The questionnaire is purposefully designed
to be of very low time and cognitive burden in order to
promote a representative participant sample amid the
often stressful context of palliative care consultation. As
such, we modeled most questionnaire items based on the
Dartmouth COOP Chart item and categorical response
structures for their strong validity and reliability in the
clinical setting [42–44]. This single-item approach pro-
motes efficient and effective measurement of multiple
constructs when sensitivity to change is not a primary
methodological priority. We performed iterative cognitive
interviewing and pilot testing for each questionnaire item
and for the final instrument to ensure question compre-
hension, appropriate response options and minimal bur-
den. The usual time for completion is fewer than 10 min.
Table 1 shows the specific questions and response options
in the order that they are asked. We identify the relevant
constructs for each item and reference sources that we
used in their original or modified form.
Palliative care clinician baseline questionnaire
Each participating palliative care clinician completes a
self-administered baseline questionnaire once at the time
of consent. The questionnaire takes fewer than 20 min
to complete and collects information about age, gender,
ethnicity/race, religious affiliation, professional training,
clinical practice type, and clinical experience. Given our
emerging understanding of clinician mindfulness in fos-
tering patient-centered communication [45], we include
a shortened version of the Mindfulness Attention
Awareness Scale [46] that included the following 5-items
about situational attention: “I find it difficult to stay fo-
cused on what’s happening in the present.”; “I forget a
person’s name almost as soon as I’ve been told it for the
first time.”; “It seems I am “running on automatic,” with-
out much awareness of what I’m doing.”; “I find myself
listening to someone with one ear, doing something else
at the same time.”; “I find myself preoccupied with the
future or the past.” Response options included the fol-
lowing 6 categories: “Almost Always”; “Very Frequently”;
“Somewhat Frequently”; “Somewhat Infrequently”; “Very
Infrequently”; “Almost Never”. Clinicians were also
asked the following two open ended questions about
perceived needs: “When thinking about having conversa-
tions with patients and families about ‘what to expect’,
are there things that you would find helpful to prepare
you, the team or the patient for such conversations?”
and “When thinking about having conversations with
patients and families about matching treatment options
to their values and preferences, are there things that you
would find helpful to prepare you, the team or the pa-
tient for such conversations?”
Digital audio recordings
We observe and digitally record consultations with con-
senting participants. After obtaining written informed
consent, the study research assistant places a hand-held
recorder with a built-in multi-directional microphone in
an unobtrusive location in the hospital room (eg. bedside
tray table). Prior to entry of the palliative care team, the
study research assistant initiates the recording and
returns after the visit to stop the recording. (Participants
are shown how to stop the recorder if they wish to do so
at any time during the visit.) Our approach yields high
fidelity recordings that allow the coder to hear even
weak voices amid clinical background noises, such as
high flow oxygen, intravenous fluid pumps and heart
rate/respiratory rate monitors.
Fig. 1 PCCRI Introductory Informational Brochure*. *for space,
removed brochure flaps containing research contacts and Human
Subjects Review Board approvals
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Table 1 Patient questionnaire measures
Question Response Construct Source
a1. Considering all parts of your life – physical,
emotional, social, spiritual, and financial – over
the past two days, how would you rate your
quality of life?
0-10 scale QOL- Global McGill Quality of Life Questionnaire,
Global item [61, 62]
Very Bad (0)
Excellent (10)
2. Over the past two days, how much have you
been bothered by physical problems such as pain,
upset stomach or difficulty breathing?






3. Over the past two days, how much have you
been bothered by emotional problems such
as feeling anxious, depressed, irritable, or
downhearted and blue?





4. Over the past two days, how much have you
been bothered by uncertainty about what to
expect from the course of your illness?
Not at all QOL- Prognostic
Uncertainty
Modified from Dartmouth COOP Chart
(“Bothered by”) [43] and “what to expect from




5. Over the past two days, how much have
you felt at peace?





a6. Over the past two days, how much have
you felt heard and understood by the doctors,




Modified from the Healthcare Climate
Questionnaire [65] and the Patient Perceptions




7. – 10. Gender (including transgendered),
Ethnicity, Race, Education
11. When you think about the amount of
income that you have available in a typical
month, how often is it enough for things
you really need like food, clothing, medicine,
repairs to the home, and transportation?
All of the time Financial Strain Modified from VOICE Study [49]
Most of the time
Some of the time
None of the time
12. How well does the following statement









13. What religions, if any, do you maintain a








14. How much are your spiritual needs being
supported by a religious community (like clergy




Coping with Cancer Study [69]
Quite a bit
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Direct observation checklist and field notes
When space in the hospital room allows, the study re-
search assistant will observe the conversation from a dis-
tance that is outside the immediate conversational space.
All research assistants have clinical experience in the
hospital environment (eg. nursing, speech pathology)
and undergo training in field observation methods. The
observer role is not to be a participant, nor is it to be
completely inanimate. Instead, observers are trained to
have a human presence without disturbing the natural
clinical processes. For example, if an IV pump alarm is
beeping during the conversation, the observer would not
mute the sound (even though they know how to do this
safely). If asked, observers kindly decline offering clini-
cians feedback or to recall any details about the conver-
sation. However, if the patient asked the observer to
pass them a cup of water from their tray or to help them
find their nurse call button, then the observer would
certainly do so if no clinical team member was available
at the moment to help. We purposefully hire observers
who have clinical experience in hospital settings and
professional interest in research. Observers undergo
weeks of practice prior to actual observation—and then
weekly meetings thereafter—in order to navigate the nu-
ance of being present but not disruptive. Observers meet
weekly and ad hoc with each other and Study Investiga-
tors, as well, to provide supportive space for dealing with
(and celebrating) the intensities of the human experience
that they are present to observe (including suffering,
joys) [47].
Immediately after the conversation, the research assist-
ant observer completes a field note that includes a stan-
dardized direct observation checklist about the following
environmental factors: number of persons in the room;
proportion of people from clinical teams and proportion
from family; hospital floor and room type; ambient noise
and heat levels, type and intensity of ambient light; type
and intensity of ambient smells; amount of foot traffic




15. How much are your spiritual needs being










16. How would you describe the purpose







A. “to help you live longer?” (for each a-c)
B. “to help you feel better?”
C. “to get rid of all the cancer?”
17. Would you say that it is likely or unlikely
that you will live for a year or longer?
Very Likely Self-Reported
Life Expectancy





18. How strongly do you agree or disagree
with the following statement?
Strongly Agree End of Life
Treatment
Preferences
Modified from SUPPORT Study [1, 71]
Somewhat Agree
Not sure
“During the last few months of my life, I would
prefer a plan of treatment that focused on my
comfort and quality of life, even if that meant
not living quite as long.“
Somewhat Disagree
Strongly Disagree
a asked at baseline questionnaire and on the calendar day following the initial recorded conversation, changing “Over the last 2 days…” to “Today…” on the
latter assessment
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in/out of the room during the conversation; and whether
the conversation contained any mention of expected sur-
vival time, fears of death/dying, artificial hydration or
nutrition, or religious or spiritual beliefs. In addition, re-
search observers qualitatively describe any noticeable
barriers to the patient being able to speak during the
conversation (eg. intubation, prolonged nebulizer treat-
ment, BIPAP, extreme weakness, other) and their im-
pressions of key non-verbal interactions or “moments”
during the recorded conversation.
Patient/Proxy post-consultation questionnaire
On the day following the pre-consultation questionnaire
and audio-recorded consultation, participants are asked
two questions post-consultation that they were asked on
the pre-consultation questionnaire: Global QOL (Item 1,
Table 1) & Perception of Patient Centered Communica-
tion (Item 6, Table 1). We changed the time of reference
in the root of each question to “today” from “the last
2 days” to avoid overlap in time period assessed on the
pre-consultation questionnaire. These two items were
selected because of their potential importance to under-
standing mediators of the association between palliative
care communication and EOL treatment outcomes. We
chose to wait until the following calendar day (instead of
directly after the consultation) to allow opportunity for
any initial treatment changes (eg. pain medications) or
identified information needs (eg. details about a specific
treatment option from the oncologist) arising form the
recorded consultation to have occurred. Patients en-
rolled on a Friday completed post-consultation question-
naires on the following Monday. Date and time of
completion are recorded for analytic purposes.
During pilot testing, we found that a total of 20 items
(18 pre-consultation, 2 post consultation) represented an
important threshold for patients/proxies as they consid-
ered study participation—more items were often per-
ceived as overly burdensome. Additionally, we found
that clinical condition of seriously ill patients often
changed rapidly; the two selected post-consultation
items were of very low burden cognitively and emotion-
ally for participants to complete.
Palliative care clinician post-consultation questionnaire
Immediately after each audio-recorded consultation, the
participating PC clinician completes a self-administered
questionnaire consisting of the following 3-items about
the patient’s condition and treatment:
a. Treatment Goals: “How would you describe the
current status of [Patient Name]’s decisions about
their medical treatments after consulting with the
PC team? (best guess)” Response options are based
on the categories commonly recorded in Medical
Orders for Life Sustaining Treatments
documentation that palliative care providers use
frequently: “No limitations to the types of medical
treatments”; “Some limitations to the types of
medical treatments”; “Comfort Measures Only
approach to medical treatments”; and “Unknown or
Undecided”.
b. Survival Prognosis: “How would you describe
[Patient Name]’s most likely survival time, assuming
that their illnesses are allowed to take their natural
course? (best guess)” Response options: “fewer than
24 h”; “days to fewer than 2 weeks”; “2 weeks to
fewer than 3 months”; “3 months to fewer than
6 months”; “6 months or longer”. We chose these
response options because these intervals are
commonly used in clinical practice for establishing
potential hospice (inpatient, outpatient) and
comfort-care home eligibility in both Rochester and
San Francisco areas.
c. Functional Status: Palliative Performance Scale (PPS
reference card provided) [48]
In-depth interview with patients/proxies post consultation
(sub-sample)
Using a criterion-based sampling strategy, the research
assistant invites selected patients/proxies to participate
in an open-ended interview following the completion of
the post-consultation questionnaire. The research assis-
tants, who are trained in qualitative interviewing tech-
niques, conduct a 20–60 min interview using open-ended
questions (with probes) exploring the following domains:
what patients/proxies find important to think about when
making decisions about their current and future care; how
the patient’s past experiences in health care may be influ-
encing their current experience; recalled experiences that
may help guide patients in making medical treatment de-
cisions; the importance of religion and/or spirituality as
they think about their healthcare choices; what they are
expecting in the future; what may have surprised them
about their meeting with the palliative care team; what
parts of their palliative care conversations have been most
important to them; and whether there were other things
in the conversation that they might want to address.
Conversation coding
We will use established methods to reliably code do-
mains of Patient-Centered Prognosis Communication
[15, 20, 21, 24] described in the Conceptual Foundation.
We train two coders for approximately 30 h over a two-
week period of time using a detailed codebook and
example transcripts. The codebook includes precise defi-
nitions and examples of what should and should not be
coded. After the initial training period, we double code
20 % of conversations distributed over the full coding
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period to identify and prevent drift in coder practice.
Using this approach, we have demonstrated excellent
inter-rater reliabilities for prognosis content (kappa >0.70)
[20, 21].
Using professional transcriptions, coders evaluate each
speaker turn in the conversation, referred to as a seg-
ment, for the presence of prognosis content. As de-
scribed earlier, we define prognosis communication to
include any prediction about the future course of illness,
including symptoms, survival, cure or functional status.
Coders will then sub-classify each occurrence of progno-
sis content as described in Table 2.
Given the early state of science related to prognosis
communication, the individual PCCRI codes are agnostic
with regards to what is considered “good” a priori
(which differs slightly from related clinical trials [49])
Rather, our approach is purely descriptive in order to
more broadly investigate the features of conversations
that predict or mediate observed patient-centered out-
comes. Because clinical conversations are dynamic and
relational phenomena that are crafted by all participants,
we endorse an ecological approach that considers the
unit of analysis to be the conversation rather than the
individual speaker.
Table 2 Description of communication codes
Domain Description/Examples
ENGAGING in discussion
Initiator [20] First speaker of prognosis content. Includes a question or statement.
Early onset [20] Prognosis content occurring within first 5 min of conversation
Goal expression [72] My hope is that this treatment will help me to feel more energy and buy me
some time so that I can go on a cruise this summer with my family.
Mutually INFORMING
Quantity [21] Number of segments containing prognosis content
Topic [21]
Cure It is very unlikely that my cancer will be cured.
Survival I expect that you will live for days to weeks, rather than months to years.
Function You will likely need more help getting around over the next few months…
Symptoms Your shortness of breath is likely to worsen in the next weeks, and we can help…
Conditional prognoses [20] If you choose to continue transfusions, you are likely to live a little longer and likely to
spend much more time in the hospital.
Goal-linked prognoses [22] One thing I hear that you are hoping for is to live until your son’s graduation; my sense
is that there is a good chance that you will live that long….
RESPONDING to Emotiona
Type of emotion [24]
Sadness I just don’t care what happens anymore [crying], I’m so alone.
Fear/worry I’m so scared about what’s gonna happen to my family…
Anger I don’t give a [expletive] what the [expletive] doctors say, I’m gonna beat this!
Intense emotion [24] Emotion interrupts speech pattern or emotion repeated within same segment
Compassion [24] I can see that this uncertainty is a burden on you and your family; I am committed to
seeing you through this and have some ideas about how to help…
FRAMING Uncertainty
Affective cues [21]
Optimistic The good news is I expect you will live for a few more months.
Pessimistic Unfortunately, I expect you will only live for a few months.
Deductive distance [21]
Population About 30 % of people die within one month.
Individual I believe that there is a 30 % chance you will die within one month.
Ambiguous [73] Things ahead look pretty good.
Your prognosis is poor but nobody can predict the future.
aemotion that is identifiably about prognosis based on the language used within the statement or within the segment directly following another
prognosis-containing segment
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Analyses
Overview
This is a mixed methods study designed to understand
the features of prognosis conversations that are associ-
ated with patient-centered outcomes. The study includes
both epidemiological (quantitative) and ethnographic
(qualitative) methods. Below, we describe each separately
and identify how they inform one another.
Approach to epidemiological analyses
We will describe the frequency and distribution for each
study variable. For descriptive analyses, we will examine
the crude relation between conversation features and
outcomes. For the purposes of sample size determin-
ation, we consider the specific association between con-
versation features and decision to pursue a comfort-
oriented plan of care. For this outcome, we define a
comfort-oriented plan of care as that which meets
BOTH of the following considerations: 1) Within two-
weeks of the index conversation, EITHER (a) enrollment
in hospice or (b) a “Comfort Measures Only” plan of
care documented in the patient’s Medical Orders for Life
Sustaining Treatments (MOLST). The specific language
used in the MOLST document is: “The patient is treated
with dignity and respect. Reasonable measures are made
to offer food and fluids by mouth. Medication, position-
ing, wound care, and other measures are used to relieve
pain and suffering. Oxygen, suction and manual treat-
ment of airway obstruction are used as needed for com-
fort.” and 2) No aggressive life-sustaining treatment
following election of (a) or (b) above until death (or end
of the 6-month follow-up period). We use the following
three indicators of “aggressive life-sustaining treatment”
as established by the Dartmouth Atlas Project as having
little or no benefit to any patients with advanced cancer:
endotracheal intubation, feeding tube placement or car-
diopulmonary resuscitation [50]. In order to achieve
standard hypothesis parameters (alpha = 0.05, beta =
0.20), we require 72 cases (with at least one control per
case) to identify a difference of 0.5 SD in conversation
features. In recognition that effect sizes are likely to be
larger than this, we will remain cognizant of the likeli-
hood that our study will be overpowered for some asso-
ciations under study.
We will stratify the crude association for each concep-
tual domain on potential confounding variables, includ-
ing the following: the patient’s race; age; gender;
educational attainment; religious affiliation; insurance;
marital status; household caregiver status; perceived so-
cial and family support; usual source of healthcare;
health literacy; cancer type; symptom burden; functional
status; physician estimate of survival prognosis; and
decision-making capacity. Factors associated with the ex-
posures and the outcome status, and influencing the
crude estimate of association will be considered as po-
tential confounders in adjusted analyses. We will adjust
for confounding using a multiple conditional logistic re-
gression model following an iterative model building
procedure where covariates are retained in the model if
their removal has a substantial influence on the observed
magnitude of association (i.e. odds ratio).
In recognition that conversations are complex phe-
nomena, we will conduct exploratory latent class ana-
lyses [51] to examine whether observed patterns among
the individual domains (i.e. ENGAGING, RESPOND-
ING, INFORMING, and FRAMING) suggest “clinical
types” of conversations that are predictive of outcomes.
Concepts of mediation
We will examine the degree to which associations be-
tween conversation features and treatment outcomes are
mediated by patients ratings of patient centered commu-
nication (feeling heard and understood) and by patient
ratings of Quality of Life (McGill Global QOL measure).
“Mediator” is equivalent to the epidemiological concept
of “causal intermediate”. Thus, we are estimating the de-
gree to which proximal communication outcomes medi-
ate the relation between the quality of prognosis
communication and preference-concordant end-of-life
medial treatment. Potential mediators are assessed using
the established measures that are collected after the re-
corded conversation and before the outcome assessment.
Pre-post changes in the McGill Global Quality of Life
item will be measured on a 0–10 continuous scale. Min-
imally Important Differences have yet to be empirically
established; therefore, we will consider 1.0 SD to repre-
sent a clinically important difference. Pre-post change in
the Patient Centered Communication item is categorical
and will be analyzed as the percent “Completely” as
shown effective for avoiding ceiling effects in medical
communication settings [52].
Assessing causation—and particularly causal pathway-
s—is challenging in non-experimental studies. Nonethe-
less, these mediating factors occur temporally between
the initial conversation and treatment outcomes and are
conceptually supported to be mediators of patient-
centered care. Therefore, this study can provide import-
ant hypothesis-generating information for subsequent
testing using experimental methods.
Measuring values and preferences for end-of-life care
Decisions about medical treatment in advanced cancer
are preference-sensitive. We measure preferences at study
outset, prior to the audio-recorded palliative care consult-
ation. This is good timing to preserve temporality of the
associations under study. However, stated preferences for
treatments in such contexts are dynamic. When consider-
ing decisions that have never been faced before, people
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often start with preferences that are either uninformed or
based on hypothetical situations. As people gather infor-
mation, their preferences often change, and are ‘con-
structed’ based on a variety of personal, informational,
affective and social factors [53, 54]. The instability in pref-
erences, however, is not symmetric. People’s preferences
are far more likely to change from aggressive cure-
oriented treatments toward comfort oriented treatments
than vice-versa [53]. Therefore, errors in assignment of
preference-concordant EOL treatment are likely direc-
tional, that is, underestimation of concordance when
comfort-oriented EOL treatment is found to occur. We
will conduct sensitivity analyses to assess potential impli-
cations of this bias.
Approach to ethnographic analyses
Each interview and corresponding audio-recorded con-
versation is professionally transcribed verbatim, de-
identified (replacing codes for spoken names) and
checked for accuracy by PCCRI research assistant. The
research assistant corrects any errors, and notes any ex-
tended pauses, emotional displays, or disruptions (eg.
people leaving the room, telephone calls). The corrected
transcript will be dated, timed, and entered into the
Atlas.ti 7.2 data management software program. Audio
files will also be imported into Atlas.ti. Atlas.ti 7.2 allows
for the integration of textual and audio data, resulting in
more efficient data management.
We will use a phased approach to analysis. In phase
one, we will use an inductive open coding approach.
During the second phase of coding, we will use our Con-
ceptual Model as a set of sensitizing concepts—ideas be-
lieved to be important to a phenomenon [55]. In phase
three, we will compare the findings from earlier phases
by examining similarities, differences, gaps and areas of
overlap. This analysis will strengthen our understanding
of how patients' prior experiences and prognosis-related
beliefs manifest within our existing conceptualizations of
prognosis communication.
We will apply our developed coding scheme to
characterize patterns of content, structure and process
among the cases, using strategies developed by Saldana,
Miles and Huberman [56].
Future analyses
The PCCRI is a comprehensive cohort study that in-
cludes recorded and transcribed conversations. As the
science of communication continues to evolve, the
PCCRI infrastructure presents extraordinary opportun-
ities for further nested studies that analyze conversations
for new content (eg. developing or evaluating new quality
indicators for palliative care practice [57]) or new methods
for measuring and understanding the complexities of
human communication (eg. natural language processing
computational linguistics [58]).
Ethics statement
This study is approved by the research review commit-
tees at the University of Rochester Medical Center and
the University of San Francisco Medical Center. This
manuscript adheres to the STROBE standards for
reporting of observational studies. We grant permission
to other scientists to use all study protocols and de-novo




The PCCRI began enrollment at the URMC site in Janu-
ary of 2014 and the UCSF site in March 2015. This re-
port covers the URMC enrollment period of January 6,
2014 to February 8, 2015. During this period, a member
of the clinical team invited 188 potentially-eligible pa-
tients to learn more about a palliative care communica-
tion research study based on the following initial
screening criteria: cancer type and stage, not enrolled in
hospice at time of referral, English speaking, decisional
capacity or known proxy present. One hundred forty
three agreed to hear more, forty-three declined and two
expressed potential interest but were ultimately not
approached due to simultaneous enrollment of other
participants. Among the 143 who were then informed
about the PCCRI by a member of the research team,
twenty-three declined participation and two wished to
participate but were seen by the palliative care team be-
fore informed consent procedures could be completed.
One hundred fourteen patients (14 % by proxy) decided
to participate and completed written informed consent.
Therefore, our initial one-year enrollment rates are 61 %
among those invited and 80 % among those informed.
Reasons for non-participation were not solicited, how-
ever the most common spontaneously volunteered rea-
sons were lack of energy, feeling overwhelmed and
wishing to wait until family members arrive (which
would occur after the enrollment window).
Patient-participant approach rate
As described above, 188 patients were invited to hear
about a communication research study. Since the re-
search screening process occurred by clinicians amid the
processes of usual care, the PCCRI collects data only
from patients who elect to participate. Therefore, the
exact number of the eligible population is not known.
Based on historical aggregate QI data from the URMC
site, 45 % of new consultations are for patients with can-
cer and 51 % of this group had full capacity to make
medical decisions. Applying these proportions to the
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observed 1,173 new patient consultations that occurred
during the January 2014 and February 2015 initial period
of PCCRI recruitment, 269 patients would have cancer
and capacity to consent for participation. We have no
data available to assess the prevalence of other eligibility
criteria. However, we estimate that the only minimal net
effects of these unknowns on the eligible population size
based on judgment that the remaining exclusions (ie.
English speaking, solid cancer, metastatic disease, and
not enrolled in hospice at time of referral) would be off-
set by the number of incapacitated patients having a
Health Care Proxy physically present at time of consult-
ation to allow proxy-based participation. Therefore, we
approximate an Approach Rate of 70 % (188 approached
/269 eligible) and a population sampling proportion of
42 % (114 enrolled/ 269 eligible).
Black/African American participants represent 12 % of
the initial PCCRI sample—a proportion nearly identical
to that observed for the palliative care clinical service
(2006–2010 historical data [21]). No patients/proxies
have expressed concerns about being invited to partici-
pate and no participants have experienced research ad-
verse events.
Clinician-participant enrollment rate
All palliative care clinicians who have been approached
for potential participation (all clinicians at the URMC
site and the initial ten at the UCSF site) enrolled in the
PCCRI.
Discussion
The Palliative Care Communication Research Initiative
is a unique cohort study that integrates self-report (pa-
tient, proxy, clinician), direct observation (field ethno-
graphic observation, audio-recording) and health services
utilization data in order to understand the characteristics
of clinical communication that promote patient-centered
outcomes. Our experience during the first year of enroll-
ment confirmed that such work is feasible, acceptable and
sustainable in the natural clinical setting of palliative care.
Nearly two out of every three patients (or proxies)
who were invited to participate chose to enroll in the
PCCRI, thus promoting generalizability. No patients re-
ported harms related to invitation or participation. We
attribute this successful experience to four key factors.
First, this study focuses on understanding communica-
tion—something that seriously ill patients and their fam-
ilies identify as in need of improvement [3, 18, 59]. We
developed the PCCRI informational brochure to make
this focus clear to potential participants (see Fig. 1). An-
ecdotally, many patients, proxies and family members
spontaneously express gratitude for being able to con-
tribute to the science of communication for future pa-
tients. The PCCRI mails participants (or their family
contacts identified at study outset) Thank You and Be-
reavement cards as well as offering to notify participants
of study findings when they become available.
Second, we minimized the burden of self-report by
using brief measures specifically designed for ease of use
and reliability the natural clinical setting [43, 44, 60].
The primary methodological trade-off is that using single
item measures with stable categorical response options
yield low sensitivity to change over time. Since most self-
report measures are being used for assessing confounding,
effect modification or mediation, we fully accept this
trade-off to promote representative sampling. Further-
more, our pilot testing of the PCCRI protocol identified a
total of 20 questions to be an important threshold that pa-
tients/proxies often weighed in their consideration of par-
ticipation. We encourage other investigators to similarly
evaluate such item threshold in their research context be-
cause we have found this single decision to have substan-
tive effects on participation rates.
Third, the PCCRI observers all have substantial clinical
experience in the hospital setting (eg. nursing, speech
pathology) and are savvy about research methods. Most
of the PCCRI observers have either completed or are
completing graduate research degrees. This background
allows the PCCRI observers to navigate the complexities
of conducting high quality research amid the substantial
and dynamic demands on the clinical team. They are
adept at balancing supporting clinical efficiency and
valid sampling/measurement. The PCCRI observers and
the PC clinicians have developed a strong and genuine
partnership that has created the energy necessary to sus-
tain this type of work.
Fourth, and likely most important, is that the PCCRI
is comprised of supportive and enthusiastic palliative
care clinical teams. The PCCRI palliative care clinicians
appreciate the need for communication research in ser-
ious illness and want to support these efforts. Indeed,
100 % decided to participate. Being observed and
audio-recorded can be uncomfortable, especially in the
intimate settings of inpatient palliative care consulta-
tion—participating in this work takes a level of trust in
the investigative team. We have found three factors, in
particular, offset this potential barrier to participation.
First, and foremost, is that the PCCRI palliative care
clinicians are comfortable with their skills and inter-
ested in promoting the science of patient-centered
communication. Without this, we do not believe that
this work would be feasible. Second, four study investi-
gators (including study PI and site PI’s) are also
physician-participants in the study, thus maintaining
awareness of the study procedures on personal vulner-
abilities and the overall clinical team functioning. (To
protect against the introduction of bias, all analyses will
evaluate whether excluding the investigator-participant
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data substantively influences the observed findings.)
Third, the PCCRI espouses a descriptive and ecological
approach to studying clinical communication rather
than a prescriptive and hypercritical one. We consider
the conversation as the unit-of-analysis and that these
phenomena are crafted by all participants in clinical
context. Our track record of publication and presenta-
tion demonstrates this objective approach that is void
of editorializing or sensationalizing [20–22, 24]. Remu-
neration of the clinicians’ time for answering question-
naires is negligible and unlikely to have any effects on
choices to participate.
This study has important limitations. First, our proto-
col does not attempt to record all interactions with the
PC team. For example, we do not approach potential
participants until they have at least had a chance to meet
a member of the PC clinical team. Although this initial
clinical PC visit is usually quite brief, our data might be
missing communication that is important to decision-
making and patient-centered care. Second, we limited
patient/proxy self report to 20 items. Although we have
found this decision to promote greater participation and
representative sample, it did require us to abandon the
systematic collection of other important data (eg. experi-
ence of social isolation/loneliness, existential QOL, ex-
perience of discrimination in the medical system). Third,
the patient/proxy questionnaire is novel; it has not been
used before. We partially address this limitation by adapt-
ing our individual questions and response options on pre-
viously validated items and by performing multiple pilot
tests in our study setting for flow, burden and comprehen-
sion. Fourth, our follow-up of patient-reported outcomes
is limited to 24 h; the remainder of the 6-month follow-up
data is collected by medical record extraction and/or com-
munication with patient-participants’ healthcare providers.
This allows for valid and reliable determination of health
services outcomes (eg. treatment, costs, survival and place
of living/death) but not for QOL and bereavement out-
comes. We will remain cognizant of these limitations in
our interpretation and dissemination of PCCRI findings.
Conclusion
In summary, early findings from the Palliative Care Com-
munication Initiative support the feasibility, acceptability
and sustainability of conducting direct-observation epide-
miologic research in the natural setting of palliative care.
Given that communication is the core “procedure” of pal-
liative care, work of this kind is crucial to understand, sup-
port and disseminate best practices for this rapidly
growing field of clinical care.
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